Clinical spectrum and prognostic impact of precipitating factors in hepatic encephalopathy among patients with liver cirrhosis: a cross-sectional observational study

Yafas Nazir Khan; Mansi; Rolanda Saint Louis; Shehla Ashraf; Purna Chand Paidi

doi:10.18203/2320-6012.ijrms20263108

Authors

Yafas Nazir Khan Department of Critical Care Unit, Sheri Kashmir Institute of Medical Sciences Soura, Srinagar, Jammu and Kashmir, India
Mansi Washington University of Health and Science, San Pedro, Belize
Rolanda Saint Louis Washington University of Health and Science, San Pedro, Belize
Shehla Ashraf Bharati Vidyapeeth Deemed University Medical College, Pune, Maharashtra, India
Purna Chand Paidi Andhra Medical College, Visakhapatnam, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263108

Keywords:

Child-Pugh class, Gastrointestinal bleeding, Hepatic encephalopathy, Infection, Liver cirrhosis, Precipitating factors, West Haven grading

Abstract

Background: Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of liver cirrhosis associated with significant morbidity and mortality. Early identification of precipitating factors is essential for timely management and improved clinical outcomes.

Methods: A hospital-based cross-sectional observational study was conducted among 110 patients with cirrhosis of liver presenting with hepatic encephalopathy at a tertiary care teaching hospital. Clinical history, physical examination, laboratory investigations, and radiological evaluation were performed to identify precipitating factors. Hepatic encephalopathy was graded using the West Haven classification, while liver disease severity was assessed using the Child-Pugh score. PHES and Stroop tests were performed in eligible patients. Clinical outcomes, including recovery and mortality, were analyzed.

Results: Most patients were middle-aged males with alcohol-related cirrhosis. Grade II hepatic encephalopathy and Child-Pugh class C were the most common presentations. Asterixis, icterus, and ascites were frequent clinical findings. At least one precipitating factor was identified in most patients, with constipation, infections, upper gastrointestinal bleeding, electrolyte imbalance, vomiting/diarrhoea, and acute kidney injury being the commonest. Neuropsychometric abnormalities were frequently detected. Higher grades of hepatic encephalopathy and advanced Child-Pugh class were significantly associated with poorer outcomes and increased mortality.

Conclusions: Hepatic encephalopathy is commonly precipitated by identifiable and potentially reversible factors. Early recognition and prompt correction of these factors, together with timely assessment of disease severity, are essential to improve prognosis and reduce morbidity and mortality in patients with liver cirrhosis.

References

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359-76.

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749-61.

Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-71.

European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatic encephalopathy. J Hepatol. 2022;77(3):807-24.

Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline. Hepatology. 2014;60(2):715-35.

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy- definition, nomenclature, diagnosis and quantification. Hepatology. 2002;35(3):716-21.

Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31(5):537-47.

Butterworth RF. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure. J Clin Exp Hepatol. 2015;5(Suppl 1):S96-103.

Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, et al. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol. 2010;25(6):1029-41.

Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004;19(3-4):253-67.

Gautam A, Sharma BC, Sarin SK. Precipitating factors of hepatic encephalopathy in liver cirrhosis. Indian J Gastroenterol. 2012;31(4):174-8.

Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S. Clinical profile and precipitating factors of hepatic encephalopathy in cirrhosis of liver. J Assoc Physicians India. 2018;66(9):38-42.

Handady SO, Ahmed ME, Elbashir MM. Precipitating factors and outcome of hepatic encephalopathy among Sudanese patients with liver cirrhosis. Sudan J Med Sci. 2017;12(1):15-22.

Poudyal NS, Chaudhary S, Kc S, Mandal BR. Clinical profile and precipitating factors of hepatic encephalopathy in liver cirrhosis. JNMA J Nepal Med Assoc. 2019;57(216):95-100.

Bharathi V, Reddy KR, Kumar A. Clinical spectrum and precipitating factors of hepatic encephalopathy in cirrhosis. Int J Adv Med. 2020;7(3):428-33.

Khungar V, Poordad F. Hepatic encephalopathy. Clin Liver Dis. 2012;16(2):301-20.

Khan M, Jamil Z, Ahmed M, Khan RA. Clinical spectrum and precipitating factors of hepatic encephalopathy in cirrhosis patients. Pak J Med Sci. 2019;35(2):468-73.

Khadka S, Acharya S, Shrestha DB. Precipitating factors of hepatic encephalopathy among cirrhotic patients admitted to tertiary care center. Ann Med Surg. 2022;81:104455.

Sethuraman R, Balasubramanian K, Prakash JA. Clinical profile and predictors of outcome in hepatic encephalopathy. Trop Gastroenterol. 2016;37(3):190-6.

Bhattarai S, Gyawali M, Khanal S, Bhandari R. Hepatic encephalopathy in liver cirrhosis: precipitating factors and outcome analysis. Kathmandu Univ Med J. 2021;19(74):141-6.

Modhavadiya Y, Shah M, Patel H. Mortality predictors in overt hepatic encephalopathy among cirrhotic patients. Cureus. 2023;15(2):e34821.

Sîngeap AM, Stanciu C, Huiban L, Cojocariu C, Girleanu I, Chiriac SA, et al. Clinical profile and outcomes in patients with hepatic encephalopathy. Exp Ther Med. 2021;22(2):822.

Rudler M, Cluzel P, Corvec TL, Benosman H, Massard J, Thabut D. Prognostic factors of overt hepatic encephalopathy in cirrhotic patients. Clin Res Hepatol Gastroenterol. 2018;42(2):124-31.

Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(1):S54-9.

Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, et al. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology. 2013;58(3):1122-32.

Sharma P, Sharma BC. Management of overt hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(1):S82-7.